These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12650124)

  • 21. The care of injection-drug users with HIV infection.
    Selbovitz LG; Zide-Selbovitz L
    N Engl J Med; 1994 Dec; 331(26):1773-4. PubMed ID: 7848484
    [No Abstract]   [Full Text] [Related]  

  • 22. The care of injection-drug users with HIV infection.
    Blansfield HN
    N Engl J Med; 1994 Dec; 331(26):1774. PubMed ID: 7984203
    [No Abstract]   [Full Text] [Related]  

  • 23. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
    AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
    Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV seroconversion among injection drug users in detention, Tehran, Iran.
    Jahani MR; Kheirandish P; Hosseini M; Shirzad H; Seyedalinaghi SA; Karami N; Valiollahi P; Mohraz M; McFarland W
    AIDS; 2009 Feb; 23(4):538-40. PubMed ID: 19182678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV prevention and psychoactive drug use: a research agenda.
    Des Jarlais DC; Semaan S
    J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.
    Wood E; Li K; Palepu A; Marsh DC; Schechter MT; Hogg RS; Montaner JS; Kerr T
    Subst Use Misuse; 2005; 40(8):1153-67. PubMed ID: 16040375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstacles to the development of prevention and public health policies in Argentina.
    Touzé G
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia.
    Ford K; Wirawan DN; Sumantera GM; Sawitri AA; Stahre M
    AIDS Educ Prev; 2004 Dec; 16(6):487-98. PubMed ID: 15585426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

  • 35. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 36. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 38. A review of barriers and facilitators of HIV treatment among injection drug users.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing syringes to injection drug users: what the family physician should know.
    Rich JD; Taylor L; Mehrotra M; Mason R; Stozek M; Stancliff S
    Am Fam Physician; 2003 Jul; 68(1):45-7. PubMed ID: 12887113
    [No Abstract]   [Full Text] [Related]  

  • 40. Sexual risk behavior in HIV-infected injection drug users.
    Battegay M; Bucher HC; Vernazza P
    Clin Infect Dis; 2004 Apr; 38(8):1175-7. PubMed ID: 15095225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.